XML 15 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Net sales $ 516,777 $ 506,102 $ 987,974 $ 978,923
Cost of goods sold 236,545 226,505 443,713 429,220
Gross profit 280,232 279,597 544,261 549,703
Selling, general and administrative expense 205,536 192,845 395,252 381,400
Research and Development Expense 52,171 46,547 100,757 93,749
Segment profit (loss) 22,525 40,205 48,252 74,554
Interest expense 5,632 4,834 11,212 9,836
Foreign exchange losses, net 1,237 2,938 2,366 6,744
Other (income) expense, net (11,208) (7,107) (12,385) (8,260)
Income before income taxes 26,864 39,540 47,059 66,234
Provision for income taxes (8,850) (11,117) (16,769) (19,993)
Net income including noncontrolling interests     30,290 46,241
Net income attributable to Bio-Rad $ 18,014 $ 28,423 $ 30,290 $ 46,241
Basic earnings per share:        
Net income per share basic attributable to Bio-Rad $ 0.61 $ 0.98 $ 1.03 $ 1.59
Weighted average common shares - basic 29,398 29,136 29,381 29,114
Diluted earnings per share:        
Net income per share diluted attributable to Bio-Rad $ 0.61 $ 0.97 $ 1.03 $ 1.58
Weighted average common shares - diluted 29,589 29,381 29,549 29,338